Pharma Deals Review, Vol 2003, No 33 (2003)

Font Size:  Small  Medium  Large

J&J to Acquire Scios

Business Review Editor

Abstract


Healthcare giant Johnson & Johnson acquires Scios in a US$2.4 B cash deal. The deal will provide J&J with Scios’ only marketed product Natrecor® (nesiritide) for acute congestive heart failure.

Full Text: pdf

Add comment

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.